Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Intercept Pharmaceuticals Inc.
DescriptionFarnesoid X receptor (FXR; NR1H4) and G protein-coupled bile acid receptor 1 (GPBAR1; TGR5) agonist
Molecular Target Farnesoid X receptor (FXR) (NR1H4) ; G protein-coupled bile acid receptor 1 (GPBAR1) (TGR5)
Mechanism of ActionFarnesoid X receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Renal (unspecified)
Indication DetailsTreat chronic kidney disease (CKD) associated with diabetic nephropathy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today